Principal Financial Group »

Lenz Therapeutics shares owned by Principal Financial Group

Quarter-by-quarter ownership of Lenz Therapeutics (LENZ) shares owned by Principal Financial Group from 13F filings

Historical chart of Principal Financial Group investment in Lenz Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Lenz Therapeutics held by Principal Financial Group consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Lenz Therapeutics by Principal Financial Group

Quarter filed Position value Share count Share price at filing
2025-09-30 $834k 18k 46.58

More positions owned by Principal Financial Group

Microsoft Corporation (MSFT)
NVIDIA Corporation (NVDA)
Apple (AAPL)
Amazon (AMZN)
Brookfield Corp Cl A Ltd Vt Sh (BN)
TransDigm Group Incorporated (TDG)
Broadcom (AVGO)
Alphabet Cap Stk Cl A (GOOGL)
Hilton Worldwide Holdings (HLT)
Meta Platforms Cl A (META)
Heico Corp Cl A (HEI.A)
O'reilly Automotive (ORLY)
Principal Exchange Traded Us Mega Cp Etf (USMC)
Kkr & Co (KKR)
Vulcan Materials Company (VMC)

View all positions for Principal Financial Group

Top funds holding Lenz Therapeutics

RA Capital Management
Falcon Edge Capital
Versant Venture Management
BlackRock
Vanguard Group
UBS Group
Paradigm Biocapital Advisors
72 Investment Holdings
Tang Capital Management
Rtw Investments
First Light Asset Management
Adage Capital Partners GP
Franklin Resources
Morgan Stanley
Geode Capital Management

View all funds holding Lenz Therapeutics